Frank Talk: August tariff wave could hit pharma and consumers hard

As the US tariff machine rolls on, the consequences are beginning to hit closer to home. In this commentary, Frank Holmes, CEO of U.S. Global Investors (NASDAQ:GROW), examines the growing impact of tariffs on American consumers, businesses, and markets. With a new wave of duties—possibly targeting pharmaceuticals—set to take effect August 1, Holmes outlines why investors should brace for higher prices, increased uncertainty, and mounting pressure on key sectors. U.S. customs duties topped $100 billion for t ...